These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9316336)

  • 21. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical focus on statins.
    Auer J; Eber B
    Curr Opin Investig Drugs; 2001 Mar; 2(3):382-8. PubMed ID: 11575709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The case for medical treatment in chronic stable coronary artery disease.
    Nash DT
    Arch Intern Med; 2005 Dec 12-26; 165(22):2587-9, discussion 2593-4. PubMed ID: 16344414
    [No Abstract]   [Full Text] [Related]  

  • 24. [Statins: possibly more than just lowering of the lipid level].
    Visseren FL; Lansberg PJ; Erkelens DW; Kastelein JJ
    Ned Tijdschr Geneeskd; 2000 Feb; 144(7):316-21. PubMed ID: 10707742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA; Sacks J
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins in coronary artery disease: beyond cholesterol reduction.
    Gambhir DS; Gambhir J
    Indian Heart J; 1997; 49(3):257-61. PubMed ID: 9291645
    [No Abstract]   [Full Text] [Related]  

  • 27. [New treatment strategies in coronary disease].
    Bourassa MG
    Union Med Can; 1993; 122(6):462-8. PubMed ID: 8303790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lowered cholesterol beneficial for vascular endothelium].
    Strandberg T; Tikkanen MJ
    Nord Med; 1996 Jan; 111(1):10-2. PubMed ID: 8570400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial function and coronary risk reduction: mechanisms and influences of nitric oxide.
    Fair JM; Berra K
    Cardiovasc Nurs; 1996; 32(3):17-22. PubMed ID: 8697489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron emission tomography and the changing paradigm in coronary artery disease.
    Schelbert HR
    Z Kardiol; 2000; 89 Suppl 4():IV55-60. PubMed ID: 10810777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction in coronary heart disease: clinical and anatomical considerations.
    Satler LF; Pearle DL; Rackley CE
    Clin Cardiol; 1989 Aug; 12(8):422-6. PubMed ID: 2670383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins in acute coronary syndromes.
    Reinhardt SC; Vaughan CJ
    Drugs Today (Barc); 2002 May; 38(5):339-50. PubMed ID: 12532169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statins in the medical management of postoperative coronary artery bypass.
    Alexander JC
    Chest; 2005 Feb; 127(2):423-4. PubMed ID: 15705974
    [No Abstract]   [Full Text] [Related]  

  • 34. Review of the major intervention trials of lowering coronary artery disease risk through cholesterol reduction.
    Stark RM
    Am J Cardiol; 1996 Sep; 78(6A):13-9. PubMed ID: 8875970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should intensive cholesterol lowering play a role in the management of acute coronary syndromes?
    Waters DD; Azar RR
    Am J Cardiol; 2000 Oct; 86(8B):35J-42J; discussion 42J-43J. PubMed ID: 11081447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regression of coronary artery disease as a result of intensive lipid-lowering therapy.
    N Engl J Med; 1991 Apr; 324(16):1133-5. PubMed ID: 2008188
    [No Abstract]   [Full Text] [Related]  

  • 37. Cholesterol lowering and coronary vasomotion.
    Jialal I
    N Engl J Med; 1995 Aug; 333(5):324-5. PubMed ID: 7596390
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of endothelial dysfunction in coronary artery disease and implications for therapy.
    Kinlay S; Ganz P
    Am J Cardiol; 1997 Nov; 80(9A):11I-16I. PubMed ID: 9375937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From heart surgery to prevention.
    Sprecher DL
    Am J Cardiol; 1998 Nov; 82(10B):66T-71T. PubMed ID: 9860379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial function as a therapeutic target in coronary artery disease.
    Sharma N; Andrews TC
    Curr Atheroscler Rep; 2000 Jul; 2(4):303-7. PubMed ID: 11122758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.